Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-08-03 4:59 pm Sale | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 81,187 1.000% | -655,295 (-88.98%) | View |
| 2023-07-17 07:30 am Sale | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 736,482 8.700% | -92,639 (-11.17%) | View |
| 2023-04-10 4:40 pm Sale | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 829,121 9.500% | -178,795 (-17.74%) | View |
| 2023-03-28 11:16 am Purchase | 13D | Aceragen Inc. ACGN | Chopra Atul | 1,469,482 17.400% | 1,469,482 (New Position) | View |
| 2023-02-14 4:39 pm Purchase | 13G | Aceragen Inc. ACGN | Castellina Ventures Ltd. | 276,999 3.300% | 276,999 (New Position) | View |
| 2023-01-30 4:30 pm Purchase | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 1,007,916 11.350% | 1,007,916 (New Position) | View |
| 2023-01-18 4:54 pm Purchase | 13D | Aceragen Inc. ACGN | NovaQuest Co-Investment Fund XV L.P. | 909,326 9.700% | 909,326 (New Position) | View |
| 2022-10-05 4:35 pm Unchanged | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 17,134,610 19.900% | 0 (Unchanged) | View |
| 2022-06-30 5:58 pm Unchanged | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 17,134,610 19.900% | 0 (Unchanged) | View |
| 2022-06-24 4:54 pm Unchanged | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 17,134,610 19.900% | 0 (Unchanged) | View |
| 2022-06-07 4:36 pm Purchase | 13G | Aceragen Inc. ACGN | Castellina Ventures Ltd. | 2,801,000 5.300% | 601,000 (+27.32%) | View |
| 2022-02-08 1:31 pm Purchase | 13G | Aceragen Inc. ACGN | Castellina Ventures Ltd. | 2,200,000 4.200% | 23,530 (+1.08%) | View |
| 2021-06-07 5:25 pm Sale | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 17,134,610 19.900% | -1,600 (-0.01%) | View |
| 2021-04-09 5:14 pm Sale | 13G | Aceragen Inc. ACGN | BAKER BROS. ADVISORS LP | 2,088,464 4.900% | -2,552,847 (-55.00%) | View |
| 2021-03-31 9:02 pm Sale | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 17,136,210 19.900% | -1,717,218 (-9.11%) | View |
| 2021-02-12 3:45 pm Sale | 13G | Aceragen Inc. ACGN | Castellina Ventures Ltd. | 2,176,470 6.200% | -71,868 (-3.20%) | View |
| 2021-01-29 4:38 pm Sale | 13G | Aceragen Inc. ACGN | BAKER BROS. ADVISORS LP | 4,641,311 12.100% | -54,791 (-1.17%) | View |
| 2020-12-30 09:16 am Purchase | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 18,853,428 19.900% | 18,853,428 (New Position) | View |
| 2020-08-17 4:30 pm Purchase | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals I LP | 14,822,075 19.900% | 8,567,968 (+137.00%) | View |
| 2020-05-06 9:59 pm Purchase | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals I LP | 6,254,107 18.600% | 2,835,883 (+82.96%) | View |